Design Therapeutics Inc (DSGN)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -19.78M | -21.65M | -22.6M | -18.82M | -15.12M | -14.4M | -15.04M | -16.25M |
Pre Tax Income | -17.34M | -19.29M | -19.94M | -15.79M | -11.84M | -11.11M | -11.79M | -13.04M |
Net Income | -17.34M | -19.29M | -19.94M | -15.79M | -11.84M | -11.11M | -11.79M | -13.04M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -17.73M | -19.29M | -19.94M | -15.79M | -11.84M | -11.11M | -11.79M | -13.04M |
EBITDA | -19.66M | -21.52M | -22.46M | -18.69M | -14.98M | -14.26M | -14.89M | -16.09M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 834k | 226k | 0 | 0 | 0 |
Operating Income | -1.91M | -8.33M | -35.83M | -67.59M | -78.19M |
Pre Tax Income | -2.05M | -8.28M | -35.53M | -63.31M | -66.86M |
Net Income | -2.05M | -8.28M | -35.53M | -63.31M | -66.86M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.131 | -0.519 | -0.641 | -1.133 | -1.194 |
EBIT | -2.05M | -8.28M | -35.53M | -63.31M | -66.86M |
EBITDA | -1.91M | -8.33M | -35.7M | -67.19M | -77.65M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.